Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6

A new experimental NS5A inhibitor, GS-5816, was shown to be safe and effective when used in an interferon- and ribavirin-free dual regimen with sofosbuvir (Sovaldi) for people

Published
17 April 2014
By
Liz Highleyman
'Chem sex' commonly reported by UK gay men diagnosed with shigella

 'Chem sex' (taking recreational drugs during sex) and attendance at sex parties are commonly reported by UK gay men with shigella infection, according to research presented to

Published
17 April 2014
By
Michael Carter
Bug chasing and me

Recently I have come into contact with a number of people on online who have asked me to “poz” them. How did a virus like HIV become fetishized, and what happens when they become positive?

Published
17 April 2014
From
Beyond Positive
HIV-infected people may face obligatory fingerprinting in Russia

A new bill prepared by a nationalist MP and approved by federal ministries proposes the introduction of obligatory fingerprinting for all people with dangerous diseases, including HIV, and the creation of a national database.

Published
17 April 2014
From
Russia Today
NHS England agrees funding for life-saving hepatitis C drug

NHS England has approved an £18.7 million investment in a new drug for the treatment of hepatitis C. Around 500 patients with acute liver failure, and/or awaiting liver transplantation, are expected to benefit from the decision to fund Sofosbuvir.

Published
17 April 2014
From
NHS England (press release)
A tale of two women dealing with HIV and self-stigma

Zimbabwean people living with HIV recently took part in a 12-week course on dealing with self-stigma and other negative thoughts that people have in relation to themselves. The initiative was different in the sense that previous efforts to address HIV-related stigma have focused on “changing people out there,” the project manager, Nadine Ferris France told us. “We don’t have many programmes that are actually focused on us, programmes that are dealing with the negative thoughts that we have about ourselves and that’s self-stigma,” she said.

Published
17 April 2014
From
Key Correspondents
England: Patients with end-stage liver disease caused by hepatitis C to get new drug

The NHS is to pay for around 500 people with end-stage liver disease caused by hepatitis C to receive Sofosbuvir, a new drug which could cure them, without waiting for guidance from the advisory body, Nice.

Published
17 April 2014
From
The Guardian
As a doctor, I’d rather have HIV than diabetes

One of the most feared diseases in the world is now, for British doctors, a manageable chronic condition. It’s a triumph we’re oddly scared to talk about

Published
17 April 2014
From
The Spectator
Px Wire: Long-Acting Injectables

In this issue, we review the research on long-acting injectable antiretrovirals for treatment in HIV-positive people and PrEP in HIV-negative people. The pathways for developing these products have key similarities as well as differences—and as the same drugs advance for treatment and PrEP, it will be key to communicate these.

Published
17 April 2014
From
AVAC
BMS combination cures 90% of genotype 1b hepatitis C in 24 weeks

A combination of two direct-acting antivirals developed by Bristol-Myers Squibb (BMS) cured 90% of previously untreated people with genotype 1b hepatitis C infection in 24 weeks, without

Published
17 April 2014
By
Keith Alcorn
← First12345...1714Next →

Filter by country